GS
63
3
NEE
39
-5
NOV
40
-5
HUM
28
-6
C
39
2
PRU
47
5
APD
57
2
CMCSA
46
-2
CMG
69
3
NTRS
39
2
ADI
65
3
GME
62
2
EQR
64
2
FITB
48
3
EQT
27
-6
AMZN
58
-2
SCHW
48
2
LUV
63
-2
EXR
57
2
SYF
83
5
GS
63
3
NEE
39
-5
NOV
40
-5
HUM
28
-6
C
39
2
PRU
47
5
APD
57
2
CMCSA
46
-2
CMG
69
3
NTRS
39
2
ADI
65
3
GME
62
2
EQR
64
2
FITB
48
3
EQT
27
-6
AMZN
58
-2
SCHW
48
2
LUV
63
-2
EXR
57
2
SYF
83
5
Financhill
Back

Keros Therapeutics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
19

KROS
Keros Therapeutics

Last Price:
44.61
Seasonality Move:
4.22%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
37.44
Seasonality Move:
3.65%
Sell
19
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $44.65. The Score for KROS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $44.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.03 Sell
Relative Strength Index (14 RSI): 30.78 Sell
Chaikin Money Flow: 146933 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.82 - 51.78) Sell
Bollinger Bands (100): (51.25 - 64.95) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.81 Sell
20-day SMA: 48.33 Sell
50-day SMA: 53.65 Sell
200-day SMA: 46.74 Sell
8-day EMA: 47.26 Sell
20-day EMA: 49 Sell
50-day EMA: 52.56 Sell
200-day EMA: 50.31 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):